Arthur Becker Discusses About His Interest In The Real Estate And Biotech Industries

Arthur Becker is a managing partner of Madison Partners, an investment firm that specializes in real estate and biotech companies. In his early endeavors, Becker engaged in both the technology and real estate industries. He ventured into the real estate business after selling his technology company in 2011. He started by developing condominiums in New York and Miami. Arthur Becker is challenged and inspired by experts whom he works with at various stages of real estate business. He believes that successful entrepreneurship is enhanced through a blend of unrelenting drive, clarity of vision, desire to engage with colleagues and knowledge on how to adjust the vision. The entrepreneur believes that one should have adequate skills on coordinating the functions of the management team. For one to be successful in entrepreneurship, he or she should stay informed about the market. See more:

About Arthur Becker

According to The Real Deal, before joining Madison Partners, Arthur Becker worked as the chairman and CEO of ZINIO, the largest digital newsstand globally. Previously, he served as the founding CEO of Navisite, an internet technology company that offered hosting and collocation services to different corporations across the UK, US and India for close to eight years. In 2011, he sold Navisite to Time Warner. In addition, Arthur worked as a senior advisor to the Vera Wang fashion company for seven years. He studied business at Tuck School of Business, Dartmouth and Bennington College.

In an article on NY Daily News, Arthur Becker is slowly getting into the field of real estate development. As an investor, has been behind the success of big developers such as Kevin Maloney, Robert Gladstone, and Michael Stern. Recently, reports filed at the New York State Attorney General’s office indicated that the investor-turned-developer is going it alone in the sale of his condominium project, 465 Washington. He intends to make a sellout of $52.5 million. Research Capital Analytics indicates that his projects in New York City are worth $550 million. Other notable developments include three townhouses in Sullivan St. New York, which he acquired in exchange of his adjacent condominium development and the condo super tower at 111 West 57th Street. Becker has also been focusing on Bio Tech companies given that he has developed great interest in cancer therapy.